Meeder Asset Management Inc. Has $40,000 Stock Holdings in Cencora, Inc. $COR

Meeder Asset Management Inc. decreased its holdings in shares of Cencora, Inc. (NYSE:COR) by 99.1% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 127 shares of the company’s stock after selling 13,425 shares during the period. Meeder Asset Management Inc.’s holdings in Cencora were worth $40,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. United Bank increased its holdings in Cencora by 4.5% in the second quarter. United Bank now owns 7,032 shares of the company’s stock valued at $2,109,000 after purchasing an additional 305 shares during the last quarter. Nebula Research & Development LLC acquired a new position in shares of Cencora during the 2nd quarter worth about $595,000. Treasurer of the State of North Carolina grew its position in shares of Cencora by 7.9% during the 2nd quarter. Treasurer of the State of North Carolina now owns 85,534 shares of the company’s stock worth $25,647,000 after buying an additional 6,244 shares during the period. Diversify Advisory Services LLC increased its stake in shares of Cencora by 94.1% in the 2nd quarter. Diversify Advisory Services LLC now owns 2,585 shares of the company’s stock valued at $747,000 after acquiring an additional 1,253 shares during the last quarter. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main increased its stake in shares of Cencora by 26.0% in the 2nd quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 73,452 shares of the company’s stock valued at $22,025,000 after acquiring an additional 15,154 shares during the last quarter. Institutional investors and hedge funds own 97.52% of the company’s stock.

Insider Activity at Cencora

In related news, Director Lauren M. Tyler acquired 550 shares of the company’s stock in a transaction that occurred on Monday, June 22nd. The shares were acquired at an average cost of $270.23 per share, for a total transaction of $148,626.50. Following the completion of the acquisition, the director directly owned 4,359 shares in the company, valued at approximately $1,177,932.57. The trade was a 14.44% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.38% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research firms recently weighed in on COR. Evercore set a $360.00 price objective on shares of Cencora in a research note on Wednesday, April 8th. Barclays lowered their target price on shares of Cencora from $425.00 to $350.00 and set an “overweight” rating for the company in a research note on Wednesday, June 10th. Morgan Stanley set a $342.00 price target on shares of Cencora in a research report on Friday, May 8th. William Blair began coverage on shares of Cencora in a report on Tuesday, April 28th. They issued a “market perform” rating for the company. Finally, Wells Fargo & Company decreased their price target on shares of Cencora from $429.00 to $331.00 and set an “overweight” rating for the company in a report on Monday, May 11th. Eleven analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $367.75.

Cencora Price Performance

Shares of COR opened at $300.90 on Thursday. The company has a debt-to-equity ratio of 3.40, a quick ratio of 0.59 and a current ratio of 0.95. The stock has a 50 day simple moving average of $282.60 and a 200 day simple moving average of $316.76. Cencora, Inc. has a 52-week low of $244.82 and a 52-week high of $377.54. The firm has a market capitalization of $58.54 billion, a PE ratio of 23.07, a P/E/G ratio of 1.68 and a beta of 0.58.

Cencora (NYSE:COR) last posted its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). The business had revenue of $78.36 billion for the quarter, compared to the consensus estimate of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.Cencora’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same period in the previous year, the company posted $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Sell-side analysts predict that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora announced that its board has initiated a stock buyback plan on Thursday, May 21st that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the company to reacquire up to 3.9% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.

Cencora Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were given a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 annualized dividend and a dividend yield of 0.8%. Cencora’s dividend payout ratio is currently 18.40%.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.